Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ACTRN12626000924358) titled 'Personalised omega-3 supplementation in multiple sclerosis - feasibility trial' on July 28.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Primary Sponsor: Deakin Institute for Physical Activity and Nutrition
Condition:
Multiple sclerosis
Multiple sclerosis
Neurological - Multiple sclerosis
Intervention:
This is a single-arm feasibility trial evaluating a personalised omega-3 long-chain polyunsaturated fatty acid (LCPUFA) supplementation intervention in people with multiple sclerosis.
Participants wil...